BioSpace News Archive

CDC-approved technique will allow caregivers to use disposable masks up to three times

The speculations regarding using the corona virus as a weapon of bioterrorism can be used about diseases such as smallpox as well. Persistence market research report highlights the fact that though the smallpox is eradicated from the world, there are chances of an outbreak of this virus by mischievous intent of people closely associated with vaccinia virus stored in laboratories.

Growing awareness amongst the public and government is creating scope for vaccination of other diseases such as Hepatitis B. According to the PMR report, public awareness will play a vital role in the surge of hepatitis B vaccinations.

The National Kidney Registry and Viracor Eurofins announced a partnership to deliver the newly released COVID-19 antibody testing for NKR’s vast network of Member Centers.

The COVID-19 outbreak has created turbulence across the supply chain, taking a toll on the healthcare industry.

The initial projections for the flu vaccine market to reach US$8Bn by the end of 2029, is now projected to escalate even higher with the rapidly growing crisis of COVID-19.

Modifications to the outline of Study P02 requested to ensure a harmonized global study protocol complying with requirements from EMA as well as FDA

Acquisition Creates One-Stop-Shop for Medication Advisory, CE Learning Solutions, Sterile Compounding Best Practices, and Consulting and Educational Strategies for Pharmacists, Pharmacy Technicians, Prescribers, Nurses, and Clinicians

The Robert Wood Johnson Foundation will provide $50 million in immediate short-term relief to several national and community organizations to help some of the families and communities feeling the greatest strain under the COVID-19 health emergency.

Agenus Inc., an immuno-oncology company with an extensive pipeline of agents designed to activate immune response to cancers, announced that the U.S. Food and Drug Administration has granted Agenus Fast Track designation for investigation of balstilimab for the treatment of cervical cancer.